Suppr超能文献

母亲自行服用尼美舒利后,孕晚期胎儿出现严重导管狭窄。

Severe ductal constriction in the third-trimester fetus following maternal self-medication with nimesulide.

作者信息

Paladini D, Marasini M, Volpe P

机构信息

Fetal Cardiology Unit, Department of Gynecology and Obstetrics, University Federico II, Naples, Italy.

出版信息

Ultrasound Obstet Gynecol. 2005 Apr;25(4):357-61. doi: 10.1002/uog.1873.

Abstract

OBJECTIVE

This was a multicenter series of 10 cases of constriction of the fetal ductus arteriosus occurring after maternal ingestion of one or two oral doses of nimesulide, which led to emergency delivery in four cases.

METHODS

The computerized databases of three referral centers were searched for all cases of ductal constriction detected during the last 8 years in association with maternal ingestion of nimesulide. Ten cases were retrieved and represent the study population. The following variables were analyzed: gestational age at diagnosis, reason for nimesulide ingestion, total nimesulide dose, time interval between drug intake and ultrasound examination, indication for echocardiography, presence of right ventricular hypertrophy, presence of tricuspid valve regurgitation, ductal systolic and diastolic peak velocities, ductal pulsatility index, signs of fetal heart failure, pregnancy and feto-neonatal outcome, and ductal status at neonatal echocardiography.

RESULTS

Nimesulide ingestion was the result of self-medication in all cases. The mean gestational age at diagnosis was 36.3 weeks and the mean time interval between nimesulide intake and echocardiographic examination was 2.9 days. The five cases with ductal peak velocities > 2.5 m/s showed right ventricular dysfunction with significant tricuspid regurgitation. At echocardiography performed immediately after birth, the ductus appeared closed in all cases and two neonates showed persistent pulmonary hypertension requiring intermittent positive pressure ventilation and nitric oxide therapy for 1 week.

CONCLUSIONS

Although the true incidence of the adverse effect of nimesulide ingestion during pregnancy cannot be deduced, we believe that patients and their clinicians should be alerted to the possibility that clinically significant ductal constriction may follow maternal self-medication with just one or two oral doses of nimesulide, at least if the drug is taken near term.

摘要

目的

这是一项多中心研究,涉及10例胎儿动脉导管狭窄病例,这些病例发生在母亲口服一或两剂尼美舒利之后,其中4例导致紧急分娩。

方法

检索了三个转诊中心的计算机数据库,以查找过去8年中检测到的与母亲服用尼美舒利相关的所有动脉导管狭窄病例。共检索到10例病例,作为研究对象。分析了以下变量:诊断时的孕周、服用尼美舒利的原因、尼美舒利总剂量、服药与超声检查之间的时间间隔、超声心动图检查的指征、右心室肥厚的存在情况、三尖瓣反流的存在情况、动脉导管收缩期和舒张期峰值速度、动脉导管搏动指数、胎儿心力衰竭的体征、妊娠及胎儿-新生儿结局,以及新生儿超声心动图检查时动脉导管的状态。

结果

所有病例中服用尼美舒利均为自我用药。诊断时的平均孕周为36.3周,服用尼美舒利与超声心动图检查之间的平均时间间隔为2.9天。动脉导管峰值速度>2.5 m/s的5例病例显示右心室功能障碍并伴有明显的三尖瓣反流。出生后立即进行的超声心动图检查显示,所有病例的动脉导管均已闭合,2例新生儿出现持续性肺动脉高压,需要间歇性正压通气和一氧化氮治疗1周。

结论

尽管无法推断孕期服用尼美舒利不良反应的真实发生率,但我们认为,患者及其临床医生应警惕以下可能性:母亲仅口服一或两剂尼美舒利进行自我用药后,可能会发生具有临床意义的动脉导管狭窄,至少在接近足月服药时会出现这种情况。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验